• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Silk Road Medical ENROUTE Transcarotid Stent; Stent, Carotid

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Silk Road Medical ENROUTE Transcarotid Stent; Stent, Carotid Back to Search Results
Model Number SR-0840-CS
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Numbness (2415); Obstruction/Occlusion (2422); Ischemia Stroke (4418); Thrombosis/Thrombus (4440)
Date of Event 05/05/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient experienced stent thrombosis and stroke post procedure.An enroute transcarotid stent was selected for use in a left side transcarotid artery revascularization (tcar) procedure.During the procedure, plaque prolapse was noted within the stent and a second stent was placed to reline the vessel.The procedure was completed with no notable issues.Six days post procedure, the patient returned with right side numbness.The patient was admitted and administrated with heparin drip.Imaging performed revealed stent thrombosis and an embolic stroke.There was no p2y12 test performed but the patient was switched from plavix to brilinta and eliquis.Additionally, it was reported that the patient had an intraluminal filling defect noted prior to the tcar procedure.
 
Event or Problem Description
It was reported that the patient experienced stent thrombosis and stroke post procedure.An enroute transcarotid stent was selected for use in a left side transcarotid artery revascularization (tcar) procedure.During the procedure, plaque prolapse was noted within the stent and a second stent was placed to reline the vessel.The procedure was completed with no notable issues.Six days post procedure, the patient returned with right side numbness.The patient was admitted and administrated with heparin drip.Imaging performed revealed stent thrombosis and an embolic stroke.There was no p2y12 test performed but the patient was switched from plavix to brilinta and eliquis.Additionally, it was reported that the patient had an intraluminal filling defect noted prior to the tcar procedure.
 
Additional Manufacturer Narrative
Investigation results: device history record (dhr) review: a review of the manufacturing documentation associated with this lot was performed, and it was found that nine defective unit was rejected during the final assembly of this lot.It was confirmed that the unit was properly segregated and discarded.No manufacturing deviations were identified that could be related to the reported complaint.The review did not suggest that the adverse event experienced by the customer could be related to the manufacturing process.Labeling review: review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review: a review of the enroute transcarotid stent device confirmed that the reported events are known events defined in the product's risk management documentation.These event types has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENROUTE Transcarotid Stent
Common Device Name
Stent, Carotid
Manufacturer (Section D)
Silk Road Medical
1213 innsbruck drive
sunnyvale CA 94089
Manufacturer (Section G)
Silk Road Medical Inc.
27th ave north plymouth
minneapolis MN 55447
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
+1(763)494-1632
MDR Report Key25449544
Report Number2124215-2026-30820
Device Sequence Number5840225
Product Code NIM
UDI-Device Identifier00811311020478
UDI-Public(01)00811311020478(17)270630(10)18336967
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/29/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberSR-0840-CS
Device Catalogue NumberSR-0840-CS
Device Lot Number0018336967
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/11/2026
Supplement Date Received by Manufacturer07/03/2026
Initial Report FDA Received Date06/09/2026
Supplement Report FDA Received Date07/30/2026
Date Device Manufactured07/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization;
Patient Age76 YR
Patient SexMale
-
-